Cargando…

BRAF Mutation Heterogeneity in Melanoma Lesions

Detalles Bibliográficos
Autores principales:	SAKAIZAWA, Kaori, ASHIDA, Atsuko, KINIWA, Yukiko, OKUYAMA, Ryuhei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2020
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128878/ https://www.ncbi.nlm.nih.gov/pubmed/31821518 http://dx.doi.org/10.2340/00015555-3394

Ejemplares similares

Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation
por: Kiniwa, Yukiko, et al.
Publicado: (2021)

A Case of Apocrine Carcinoma Arising in a Sebaceous Naevus: Detection of HRAS G13R Mutation
por: KATSUIE, Shiho, et al.
Publicado: (2022)

Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level
por: Sakaizawa, K, et al.
Publicado: (2012)

Erythromelalgia Associated with Neuropathy in Sjögren’s Syndrome: A Case Report
por: SAITO, Nana, et al.
Publicado: (2022)

Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy
por: OSAWA, Kana, et al.
Publicado: (2022)

Late Onset of Cardiac Metastasis of a Melanoma following Nivolumab Immunotherapy
por: Nakamura, Kenta, et al.
Publicado: (2022)

Polyclonality of BRAF mutations in primary melanoma and the selection of mutant alleles during progression
por: Lin, J, et al.
Publicado: (2011)

A Two-year-old Boy with a Depressed Area in the Groin: A Quiz
por: OSAWA, Kana, et al.
Publicado: (2022)

Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment
por: Mak, Gabriel, et al.
Publicado: (2014)

Utility of Melanin Degradation Products in the Nail for Diagnosing Nail Apparatus Melanoma
por: MIYAKE, Tomomi, et al.
Publicado: (2021)

BRAF mutations in non-Hodgkin's lymphoma
por: Lee, J W, et al.
Publicado: (2003)

Hairy cell leukaemia with unusual BRAF mutations
por: Maitre, Elsa, et al.
Publicado: (2023)

Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations
por: Heinzerling, L, et al.
Publicado: (2013)

BRAF and NRAS Mutations are Heterogeneous and Not Mutually Exclusive in Nodular Melanoma
por: Chiappetta, Caterina, et al.
Publicado: (2015)

Evaluation of EGFR, KRAS and BRAF gene mutations in renal cell carcinoma
por: Bayrak, Omer, et al.
Publicado: (2014)

A nonsense nucleotide substitution in the oculocutaneous albinism II gene underlies the original pink-eyed dilution allele (Oca2(p)) in mice
por: SHOJI, Haruka, et al.
Publicado: (2015)

BRAF(V600E )mutations in malignant melanoma are associated with increased expressions of BAALC
por: Schrama, David, et al.
Publicado: (2008)

A switch in RND3-RHOA signaling is critical for melanoma cell invasion following mutant-BRAF inhibition
por: Klein, R Matthew, et al.
Publicado: (2011)

Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma: a case series
por: Carlino, Matteo S, et al.
Publicado: (2016)

Concordance and Discordance Rates of V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)(V600E) Status in Metastatic against Primary Lesion of Melanoma: A Meta-analysis
por: Yokomichi, Hiroshi, et al.
Publicado: (2020)

Near-ultraviolet Light Dermoscopy for Identification of Pigmented Skin Tumours
por: MINAGAWA, Akane, et al.
Publicado: (2023)

Improved overall survival in dual compared to single immune checkpoint inhibitors in BRAF V600-negative advanced melanoma
por: Kartolo, Adi, et al.
Publicado: (2022)

Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma
por: Colombino, Maria, et al.
Publicado: (2013)

Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing
por: Pupo, Gulietta M., et al.
Publicado: (2017)

Potential clinical and immunotherapeutic utility of talimogene laherparepvec for patients with melanoma after disease progression on immune checkpoint inhibitors and BRAF inhibitors
por: Chesney, Jason, et al.
Publicado: (2018)

Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
por: Ascierto, Paolo A., et al.
Publicado: (2019)

Polymorphisms of the BRAF gene predispose males to malignant melanoma
por: Meyer, Peter, et al.
Publicado: (2003)

Use of Dermatoscopy in Lesions Suspicious for Melanoma: Two Case Reports
por: JANCZURA, Kevin, et al.
Publicado: (2023)

Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry
por: Bruno, William, et al.
Publicado: (2016)

Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma
por: Spagnolo, Francesco, et al.
Publicado: (2014)

Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors
por: Suzuki, Rika, et al.
Publicado: (2023)

Intra- and Inter-Tumor Heterogeneity of BRAF(V600E)Mutations in Primary and Metastatic Melanoma
por: Yancovitz, Molly, et al.
Publicado: (2012)

Assessment of epigenetic alterations in early colorectal lesions containing BRAF mutations
por: Sawada, Takeshi, et al.
Publicado: (2016)

Certolizumab pegol treatment for leg ulcers due to rheumatoid vasculitis
por: Meling, Maureen Tania, et al.
Publicado: (2021)

BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Clinical significance of BRAF mutations in metastatic melanoma
por: Chang, David Z, et al.
Publicado: (2004)

The role of BRAF V600 mutation in melanoma
por: Ascierto, Paolo A, et al.
Publicado: (2012)

Development of encorafenib for BRAF-mutated advanced melanoma
por: Koelblinger, Peter, et al.
Publicado: (2018)

Atypical BRAF and NRAS Mutations in Mucosal Melanoma
por: Dumaz, Nicolas, et al.
Publicado: (2019)

Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants
por: Spagnolo, Francesco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9e1capn1j8ehb16g0gdejrc3fp